Relationship between estrogen receptor (ER) status and efficacy of postoperative adjuvant chemotherapy with oral tegafur-uracil (UFT) or CMF: subset analysis from a randomized controlled trial (CUBC trial in Japan)

被引：2
|
作者：
Takatsuka, Y. [1 ]
Park, Y. [2 ]
Okamura, K. [3 ]
Mitsuyama, S. [4 ]
Saito, T. [5 ]
Koh, J. [6 ]
Kyono, S. [7 ]
Inaji, H. [8 ]
Koyama, H. [8 ]
Suzuki, T. [8 ]
机构：
[1] Kansai Rosai Hosp, Dept Breast Surg, Hyogo 2748510, Japan
[2] Toho Univ, Sakura Hosp, Sch Med, Chiba, Japan
[3] Kumamoto Rosai Hosp, Dept Surg, Kumamoto, Japan
[4] Kita Kyushu Municipal Med Ctr, Dept Surg, Fukuoka, Japan
[5] Omiya Red Cross Hosp, Dept Surg, Saitama, Japan
[6] Saitama Social Insurance Hosp, Dept Surg, Saitama, Japan
[7] Chiba Hokuso Hosp, Nippon Med Sch, Dept Surg, Chiba, Japan
[8] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Surg, Osaka, Japan
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 07期
关键词：
D O I：
10.1016/S1359-6349(08)70551-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：117 / 118
页数：2
相关论文
共 13 条
  • [1] Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N•SAS-BC 01 trial and CUBC trial)
    Ohashi, Yasuo
    Watanabe, Toru
    Sano, Muneaki
    Koyama, Hiroki
    Inaji, Hideo
    Suzuki, Takaichiro
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (03) : 633 - 641
  • [2] Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: A pooled analysis of two randomized controlled trials (N-SAS-BC01 trial and CUBC trial)
    Ohashi, Y.
    Watanabe, T.
    Sano, M.
    Koyama, H.
    Inaji, H.
    Suzuki, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [3] Efficacy of oral tegafur-uracil (UFT) as adjuvant therapy as compared with classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in early breast cancer: a pooled analysis of two randomized controlled trials (N·SAS-BC 01 trial and CUBC trial)
    Yasuo Ohashi
    Toru Watanabe
    Muneaki Sano
    Hiroki Koyama
    Hideo Inaji
    Takaichiro Suzuki
    Breast Cancer Research and Treatment, 2010, 119 : 633 - 641
  • [4] Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N•SAS-BC 01 trial and CUBC trial)
    Ohno, Shinji
    Saji, Shigehira
    Masuda, Norikazu
    Tsuda, Hitoshi
    Akiyama, Futoshi
    Kurosumi, Masafumi
    Shimomura, Akihiko
    Sato, Nobuaki
    Takao, Shintaro
    Ohsumi, Shozo
    Tokuda, Yutaka
    Inaji, Hideo
    Watanabe, Toru
    Ohashi, Yasuo
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 186 (01) : 135 - 147
  • [5] A randomized phase III trial of 1-year adjuvant chemotherapy with oral tegafur-uracil (UFT) vs. surgery alone in stage II colon cancer: SACURA trial
    Kajiwara, Yoshiki
    Ishiguro, Megumi
    Teramukai, Satoshi
    Matsuda, Chu
    Fujii, Shoichi
    Kinugasa, Yusuke
    Nakamoto, Yoshihiko
    Kotake, Masanori
    Sakamoto, Yoshiyuki
    Kurachi, Kiyotaka
    Maeda, Atsuyuki
    Komori, Koji
    Tomita, Naohiro
    Shimada, Yasuhiro
    Takahashi, Keiichi
    Kotake, Kenjiro
    Watanabe, Masahiko
    Mochizuki, Hidetaka
    Sugihara, Kenichi
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Long-term follow-up of two randomized controlled trials (N-SAS-BC01 trial and CUBC trial) comparing oral tegafur-uracil (UFT) versus classical cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) as adjuvant therapy in early breast cancer
    Yonemori, K.
    Ohsumi, S.
    Takao, S.
    Tokuda, Y.
    Ito, Y.
    Nakagami, K.
    Takahashi, M.
    Yoshidome, K.
    Nakayama, T.
    Yamaguchi, Y.
    Ohashi, Y.
    Inaji, H.
    Watanabe, T.
    CANCER RESEARCH, 2019, 79 (04)
  • [7] A randomized controlled trial evaluating efficacy of adjuvant oral uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: The UFT/LV study.
    Kobayashi, Akira
    Hasegawa, Kiyoshi
    Saiura, Akio
    Takayama, Tadatoshi
    Miyagawa, Shinichi
    Yamamoto, Junji
    Bandai, Yasutsugu
    Teruya, Masanori
    Yoshimi, Fuyo
    Kawasaki, Seiji
    Koyama, Hiroto
    Oba, Masaru
    Takahashi, Michiro
    Mizunuma, Nobuyuki
    Matsuyama, Yutaka
    Watanabe, Toshiaki
    Makuuchi, Masatoshi
    Kokudo, Norihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [8] Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur–uracil with CMF (N·SAS-BC 01 trial and CUBC trial)
    Shinji Ohno
    Shigehira Saji
    Norikazu Masuda
    Hitoshi Tsuda
    Futoshi Akiyama
    Masafumi Kurosumi
    Akihiko Shimomura
    Nobuaki Sato
    Shintaro Takao
    Shozo Ohsumi
    Yutaka Tokuda
    Hideo Inaji
    Toru Watanabe
    Yasuo Ohashi
    Breast Cancer Research and Treatment, 2021, 186 : 135 - 147
  • [9] Randomized Phase Ill Trial of Adjuvant Chemotherapy With Gemcitabine Compared With Oral Tegafur-uracil (UFT) in Resected, Stage IB-IIIa Non-small Cell Lung Cancer (WJTOG 0101)
    Mitsudomi, T.
    Tada, H.
    Ichinose, Y.
    Yokoi, K.
    Katakami, N.
    Oda, M.
    Negoro, S.
    Chiba, Y.
    Nakagawa, K.
    Nakanishi, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S594 - S594
  • [10] Effect of Postoperative Adjuvant Chemotherapy with Tegafur-Uracil on Survival in Patients with Stage IA Non-small Cell Lung Cancer An Exploratory Analysis from a Meta-Analysis of Six Randomized Controlled Trials
    Hamada, Chikuma
    Tsuboi, Masahiro
    Ohta, Mitsuo
    Fujimura, Shigefumi
    Kodama, Ken
    Imaizumi, Munehisa
    Wada, Hiromi
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) : 1511 - 1516
12